Vy Tran, PhD

Associate Director, Global Medical Affairs - RSV at Moderna
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Boston

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Associate Director, Global Medical Affairs - RSV
      • Jul 2023 - Present

      Cambridge, Massachusetts, United States

    • Australia
    • Biotechnology Research
    • 700 & Above Employee
    • Global Senior Medical Affairs Manager, Influenza Vaccines
      • May 2022 - Jun 2023

      United States

    • Denmark
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Field Medical Advisor & Clinical Development Manager, Rare Disease
      • Jun 2021 - May 2022

    • Clinical Development Manager, BioPharmaceuticals
      • Nov 2020 - May 2022

    • Medical Science Liaison
      • Aug 2018 - Jun 2021

      Toronto, Canada Area Hemophilia, rare blood disorders, and growth disorders

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Medical Science Liaison
      • Jan 2018 - Aug 2018

      Toronto, Canada Area Neuromuscular disorders and rare cancers As a Medical Science Liaison, I worked collaboratively with the Medical Affairs and cross-functional teams to improve patient outcomes by leading Medical Information, collaborating with Marketing, supporting clinical development, and by generating and streamlining Medical communication tools and processes.

    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Research Associate
      • Aug 2016 - Aug 2017

      Madison, Wisconsin Area

    • PhD Graduate Researcher
      • Sep 2012 - Aug 2016

      Madison, Wisconsin Area PhD research aimed at (1) engineering influenza viruses to better understand, visualize, and quantify how influenza virus infections progress and (2) using functional genomics to explore how influenza viruses infect, interact with, and ultimately take over human cells. These studies shed light on unexpected ways in which influenza viruses can repurpose human proteins during infection. This research was funded by an NIH T32 Molecular Biology Grant, yielded 5 publications, and numerous… Show more PhD research aimed at (1) engineering influenza viruses to better understand, visualize, and quantify how influenza virus infections progress and (2) using functional genomics to explore how influenza viruses infect, interact with, and ultimately take over human cells. These studies shed light on unexpected ways in which influenza viruses can repurpose human proteins during infection. This research was funded by an NIH T32 Molecular Biology Grant, yielded 5 publications, and numerous academic, government, and industry partnerships.

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Molecular Engineering Intern
      • May 2016 - Jul 2016

      Berkeley, CA As a Molecular Engineering intern, I worked to further develop the CRISPR technology platform, informing how we can use gene editing as a therapeutic. Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing. The CRISPR-Cas technology puts Caribou Biosciences at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole. Caribou Biosciences' singular focus is… Show more As a Molecular Engineering intern, I worked to further develop the CRISPR technology platform, informing how we can use gene editing as a therapeutic. Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing. The CRISPR-Cas technology puts Caribou Biosciences at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole. Caribou Biosciences' singular focus is on the advancement of new applications for CRISPR-Cas gene editing that will help bring the tremendous promise this technology holds for patients and consumers to reality. Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • Life Science Research Assistant
      • Jun 2011 - Jun 2012

    • Undergraduate Research Assistant
      • Jun 2009 - Jun 2011

      Stanford, CA Undergraduate thesis research aimed at investigating and performing initial characterization of Argonaute proteins of the amoebic parasite Entamoeba histolytica. While their sequences suggested a role in parasite gene silencing, no functions had yet been attributed to these genes. Funded by the Stanford University Undergraduate Advising and Research Major Grant .

Education

  • Stanford University
    Bachelor of Science (BS) with Departmental Honors, Biology, Microbes and Immunity
  • University of Wisconsin-Madison
    Doctor of Philosophy (Ph.D.), Microbiology

Community

You need to have a working account to view this content. Click here to join now